Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa

• Colleen F. Hanrahan ,

  * E-mail: colleen_hanrahan@unc.edu

  Affiliation University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America

  ⨯
• Katerina Selibas,

  Affiliation Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Christopher B. Deery,

  Affiliation Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Heather Dansey,

  Affiliation Witkoppen Health and Welfare Centre, Johannesburg, South Africa

  ⨯
• Kate Clouse,

  Affiliations University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America, Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Jean Bassett,

  Affiliation Witkoppen Health and Welfare Centre, Johannesburg, South Africa

  ⨯
• Lesley Scott,

  Affiliation Department of Molecular Medicine and Hematology, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Wendy Stevens,

  Affiliations Department of Molecular Medicine and Hematology, University of the Witwatersrand, Johannesburg, South Africa, National Health Laboratory Services, Johannesburg, South Africa

  ⨯
• Ian Sanne,

  Affiliation Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Annelies Van Rie

  Affiliation University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America

  ⨯